Piers | Jotup

Completes project financing and begins cruise operations at San Juan Cruise Port, Puerto Rico

Retrieved on:

Thursday, February 15, 2024

USD, Piers, Growth, Nature, Pier, SJCP, Government, Safety, Series, GPH, Tourism

Completes project financing and begins cruise operations at San Juan Cruise Port, Puerto Rico

Key Points:

Completes project financing and begins cruise operations at San Juan Cruise Port, Puerto Rico
Completes project financing and begins cruise operations at San Juan Cruise Port, Puerto Rico
Global Ports Holding Plc ("GPH" or "Group"), the world's largest independent cruise port operator, is pleased to announce that its wholly-owned subsidiary San Juan Cruise Port LLC (“SJCP”) has successfully reached financial closing of the PPP Agreement and simultaneously concluded the debt financing for the initial phase of its investment in San Juan Cruise Port and has now taken over cruise operations at San Juan Cruise Port for GPH.
The successful long-term project financing was achieved through the issuance, by San Juan Cruise Port, of two bonds totalling USD 187 million.
"We are delighted to welcome San Juan Cruise Port into the world's largest cruise port network.
I would like to thank the Government of Puerto Rico and the Puerto Rico Port Authority for their support throughout the process.

Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer

Retrieved on:

Monday, December 11, 2023

SAN, Business development, Senior, Piers, Patient, Merck & Co., Eli Lilly, Therapy, Recode, BMS, Business, Pharmaceutical industry, Medarex, Genentech

SAN FRANCISCO and SINGAPORE, Dec. 11, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the appointment of Angèle Maki, Ph.D., as Chief Business Officer, effective immediately.

Key Points:

SAN FRANCISCO and SINGAPORE, Dec. 11, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the appointment of Angèle Maki, Ph.D., as Chief Business Officer, effective immediately.
Piers Ingram, Ph.D., Chief Executive Officer and co-founder of Hummingbird Bioscience said: "We are delighted that Angèle is joining our team.
Most recently, she served as Senior Vice President and Head of Business Development at ReCode Therapeutics, where she led business development, corporate development, investor and public relations.
I believe Hummingbird Bio's approach to precision medicines and its promising clinical antibody assets will redefine the next generation of precision therapeutics," said Dr. Maki.

Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer

Retrieved on:

Monday, December 11, 2023

SAN, Business development, Senior, Piers, Patient, Merck & Co., Eli Lilly, Therapy, Recode, BMS, Business, Pharmaceutical industry, Medarex, Genentech

SAN FRANCISCO and SINGAPORE, Dec. 11, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the appointment of Angèle Maki, Ph.D., as Chief Business Officer, effective immediately.

Key Points:

SAN FRANCISCO and SINGAPORE, Dec. 11, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the appointment of Angèle Maki, Ph.D., as Chief Business Officer, effective immediately.
Piers Ingram, Ph.D., Chief Executive Officer and co-founder of Hummingbird Bioscience said: "We are delighted that Angèle is joining our team.
Most recently, she served as Senior Vice President and Head of Business Development at ReCode Therapeutics, where she led business development, corporate development, investor and public relations.
I believe Hummingbird Bio's approach to precision medicines and its promising clinical antibody assets will redefine the next generation of precision therapeutics," said Dr. Maki.

Piers Dunhill and Dunhill Ventures Featured at World Economic Forum, Le Marche International des Professionnels de L'immobilier

Retrieved on:

Tuesday, June 20, 2023

Fintech, Blockchain, High, Housing, WEF, World Economic Forum, Dunhill, MIPIM, Government, Riviera, Investment, Piers, ESG, Environment, Cryptocurrency, Bitcoin

Piers Dunhill and the Dunhill Ventures Team took the opportunity to foster dynamic conversations about future innovations in these sectors.

Key Points:

Piers Dunhill and the Dunhill Ventures Team took the opportunity to foster dynamic conversations about future innovations in these sectors.
The World Economic Forum, held annually in Davos, is a renowned platform for global leaders from business, government, and various sectors to collaborate on issues of international concern.
When asked about Dunhill Ventures' efforts within this forum, Piers commented, "Dunhill Ventures recognizes the power of collaboration and networking, and the WEF is an optimal platform for this."
Later on March 16, 2023, Piers Dunhill and the Dunhill Ventures Team hosted the Dunhill Real Estate Investor Reception in the French Riviera from 6 p.m. to 8 p.m. at the prestigious Le Marche International des Professionnels de L'immobilier ("MIPIM") conference.

Piers Dunhill & DV Founders Limited ('Dunhill Ventures') at Meta Week, EAAS and WOW Summit

Retrieved on:

Wednesday, May 24, 2023

Blockchain, Housing, PE, Energy, USD, Investment, Piers, Climate, City, ESG, Geography, Strategic sustainable investing, Environment, Cryptocurrency, Amusement park, Metaverse

The attendance of Piers and the Dunhill Ventures Team is indicative of the efforts that are required in present times to diversify client investment portfolios.

Key Points:

The attendance of Piers and the Dunhill Ventures Team is indicative of the efforts that are required in present times to diversify client investment portfolios.
Piers Dunhill is the great-great-grandson of the prestigious Dunhill Family founded by Sir Alfred Dunhill in 1893.
Piers Dunhill's business is across London, Switzerland, and Dubai, and he is an LP and GP in many funds.
Piers Dunhill is committed to ensuring that all his investments result in a positive and sustainable footprint for humanity and the environment.

Attractions Industry Expert, Tim Samson, Joins Catalate

Retrieved on:

Tuesday, February 21, 2023

Cloud, Park, Cloud storage, Morey's Piers, Communication, Marketing, PALO, DACH, Morey, IAAPA, Partnership, Piers, Dynamics, Amusement park, Catalent

PALO ALTO, Calif., Feb. 21, 2023 /PRNewswire/ -- Catalate is excited to welcome Tim Samson as Director of Sales, North America. Tim has 25 years of experience in the parks and attractions industry, most notably at Morey's Piers, a classic seaside amusement park in Wildwood, NJ. He brings varied experience across marketing, sales, operations, and analytics, all focused on ensuring highly effective park operations and business growth.

Key Points:

PALO ALTO, Calif., Feb. 21, 2023 /PRNewswire/ -- Catalate is excited to welcome Tim Samson as Director of Sales, North America.
Tim has 25 years of experience in the parks and attractions industry, most notably at Morey's Piers, a classic seaside amusement park in Wildwood, NJ.
As a former park operator and Catalate partner, Tim is uniquely suited to educate resorts and attractions considering a new e-commerce and pricing strategy about the benefits of Catalate's platform.
Tim is also a member of IAAPA's Marketing and Communications Sub-committee, where he provides meaningful insight into the overarching Park & Attractions Industry.

Signs 30-year concession agreement for San Juan Cruise Port, Puerto Rico

Retrieved on:

Wednesday, August 17, 2022

Piers, Global Ports, CEO, Technology, Growth, GPH, Partnership, Safety, Government, Puerto Rico Ports Authority, MAR, Puerto Rico Public–Private Partnerships Authority, Airline, Private investigator, Fuel oil

Signs 30-year concession agreement for San Juan Cruise Port, Puerto Rico

Key Points:

Signs 30-year concession agreement for San Juan Cruise Port, Puerto Rico
Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.
Signs 30-year concession agreement for San Juan Cruise Port, Puerto Rico
Global Ports Holding Plc ("GPH" or "Group"), the world's largest independent cruise port operator, is pleased to announce that it has signed a 30-year concession agreement with the Puerto Rico Ports Authority for San Cruise Port, Puerto Rico, following a competitive procurement process managed by the Puerto Rico Public-Private Partnership Authority.
On completion, San Juan Cruise Port, which welcomed 1.8m unique passengers in 2019 (including c. 0.4m homeport passengers, i.e.
Under the concession agreement terms, GPH will pay an upfront concession fee of $75m to the Puerto Rico Ports Authority.

Sympatic Successfully Raises Pre-Seed Round of Funding Led by Saltagen Ventures to Revolutionize Zero-Copy Data Use.

Retrieved on:

Thursday, August 4, 2022

CHICAGO, Aug. 4, 2022 /PRNewswire/ -- Sympatic, a data collaboration platform that allows users to create and manage safe data sandboxes in their cloud of choice, today announced that it has raised a pre-seed round of funding led by Saltagen Ventures with participation from ScaleGood Fund.

Key Points:

CHICAGO, Aug. 4, 2022 /PRNewswire/ -- Sympatic , a data collaboration platform that allows users to create and manage safe data sandboxes in their cloud of choice, today announced that it has raised a pre-seed round of funding led by Saltagen Ventures with participation from ScaleGood Fund .
Sympatic rethinks how data collaboration occurs and lays the foundation for a future of ethical data use.
We are thrilled to partner with Saltagen Ventures who share Sympatic's commitment to develop the next generation of zero-copy data collaboration tools."
Sympatic leverages VirtualVault technology to simplify data collaboration, increase velocity of data use and prevent data loss.

FOX News Channel to Present Special Live Coverage of Queen Elizabeth II’s Platinum Jubilee Beginning June 1st

Retrieved on:

Tuesday, May 31, 2022

FOX News Channel (FNC) will present special live coverage of Queen Elizabeth IIs Platinum Jubilee starting Wednesday, June 1st, commemorating Her Majesty the Queen of Englands 70 years of service to the United Kingdom.

Key Points:

FOX News Channel (FNC) will present special live coverage of Queen Elizabeth IIs Platinum Jubilee starting Wednesday, June 1st, commemorating Her Majesty the Queen of Englands 70 years of service to the United Kingdom.
Entitled The Platinum Jubilee of Queen Elizabeth II, the networks live coverage will highlight the life and ongoing legacy of the longest-reigning British monarch in history.
FOX News Media operates the FOX News Channel (FNC), FOX Business Network (FBN), FOX News Digital, FOX News Audio, FOX News Books, the direct-to-consumer streaming services FOX Nation and FOX News International and the free ad-supported television service FOX Weather.
5-9 AM/ET Special coverage entitled, The Platinum Jubilee of Queen Elizabeth II hosted by Ainsley Earhardt, Martha MacCallum and Piers Morgan live from outside Buckingham Palace
5-9 AM/ET Special coverage entitled, The Platinum Jubilee of Queen Elizabeth II hosted by Ainsley Earhardt, Martha MacCallum and Piers Morgan live from Park Plaza Westminster Bridge London
View source version on businesswire.com: https://www.businesswire.com/news/home/20220531005825/en/

Piers Morgan Joins Pharnext's Board of Directors

Retrieved on:

Friday, July 16, 2021

Piers

Piers Morgan has over 20 years of experience in senior biotech roles, principally as Chief Financial Officer.

Key Points:

Piers Morgan has over 20 years of experience in senior biotech roles, principally as Chief Financial Officer.
Piers Morgan was also CEO of C4X Discovery, a UK biotechnology company, which went public on AIM under his leadership.
Michel de Rosen, Chairman of Pharnext's Board of Directors, said: "We thank Jean Combalbert for his precious contribution during the time he served on our board.
Piers Morgan, new Board Member of Pharnext, said: "PXT3003, Pharnext's lead drug candidate, has the potential to address serious unmet medical need in the CMT space.